ArticleEuropean heart journal open2025
Risk factors for myocarditis hospitalization and recurrence: a state-wide retrospective observational study.
Article in European heart journal open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Myocarditis is a potentially life-threatening condition with diverse aetiologies including viral infections, toxins, and autoimmunity. We aimed to quantify the risk factors of index myocarditis hospitalization and subsequent myocarditis recurrence. Methods and results: We conducted a retrospective cohort study in New South Wales (NSW), Australia, using the Admitted Patient Data Collection (APDC) of all hospitalized patients. Conditions temporally associated with myocarditis within 30 days of the index admission were identified using conditional logistic regression analysis. In patients with previous myocarditis, risk factors for recurrent myocarditis admission were calculated with both Cox regression using cause-specific hazards and competing risk analysis. There were 4071 cases of index myocarditis from 2004 to 2021. Over a median of 4.8 years of follow-up, there were 124 patients whose myocarditis recurred. Two-thirds of cases were male with an average age of 42 years. Index myocarditis cases were much more common within 30 days of a hospitalization for pericarditis, heart failure, ventricular arrhythmias, COVID-19, and several other cardiac, respiratory, and autoimmune conditions, compared to the baseline risk over the preceding 12 months. Similarly, myocarditis recurrence was more common within 30 days of pericarditis, ventricular arrhythmias, COVID-19, and autoimmune disease. Recurrence was not strongly predicted by any features of the index myocarditis admission. Our analysis is solely based on administrative coding, with limited clinical validation, which introduces potential for misclassification. Conclusion: In our cohort, myocarditis was more frequently diagnosed following presentations with acute respiratory illness (including COVID-19), autoimmune conditions, or cardiac events including ventricular arrhythmias, atrial fibrillation, and heart failure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.